The pharmaceutical company reported $24.1 billion in revenue during the quarter, with COVID-19 vaccine sales driving most of its growth.

Join The Ecosystem

Leave a Reply

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}